A study found that pulmonary hypertension often resolves within a year in premature infants with BPD, though many still ...

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Please provide your email address to receive an email when new articles are posted on . In the setting of bronchopulmonary dysplasia, pulmonary hypertension appeared associated with lengthier ...

In infants with bronchopulmonary dysplasia (BPD), development of late pulmonary hypertension (PH) was associated with a higher mortality rate, longer duration of hospital stay, and higher healthcare ...

Please provide your email address to receive an email when new articles are posted on . Caring for premature babies with bronchopulmonary dysplasia, which is a serious lung condition that occurs in ...

Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...

High blood pressure can indirectly cause shortness of breath by forcing the heart to work harder, which may lead to cardiovascular issues. Pulmonary hypertension, a specific type of high blood ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

Reduced diffusing capacity of the lungs for carbon monoxide (DLco) reflects microvasculopathy in chronic thromboembolic ...